Form 4: Cerus Corp Executive Chrystal Jensen Reports Stock Transactions

Chrystal Jensen, Chief Legal Officer of Cerus Corporation, reports the acquisition and disposal of common stock and restricted stock units (RSUs).

Summary

• On March 6, 2025, Chrystal Jensen, Chief Legal Officer of Cerus Corporation, acquired 385,000 shares of common stock and 69,577 RSUs.
• The RSUs are part of the 2024 Equity Incentive Plan.
• Some RSUs vest in two annual installments: 34% on March 12, 2026, and 66% on March 12, 2027, contingent upon continuous service.
• Other RSUs were granted as part of the 2024 annual bonus and were fully vested upon grant.
• On March 7, 2025, Jensen sold 27,457 shares of common stock at an average price of $1.498 per share to cover tax obligations related to vesting RSUs.
• Following these transactions, Jensen beneficially owns 832,318 shares of common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions are standard for executive compensation and tax obligations. No clear positive or negative implications for the company's outlook.

Positives

• The grant of RSUs to a key executive like the Chief Legal Officer can be seen as a positive incentive for continued service and alignment with company goals.

Negatives

• The sale of shares, even if for tax obligations, could be interpreted negatively by some investors, although it's a common practice.

Risks

• The vesting of RSUs is contingent upon continuous service, creating a potential risk if the executive were to leave the company before the vesting dates.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedule of the RSUs implies an expectation of continued service from the executive.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Monitoring these transactions can provide insights into management's confidence in the company's future prospects.

Comparison to Industry Standards

• Equity compensation is a standard practice across the biotechnology industry, often used to attract and retain key personnel.
• Vesting schedules similar to the one described are common, aligning executive incentives with long-term company performance.
• Sales of shares to cover tax obligations are also a typical occurrence among executives with equity compensation.

Stakeholder Impact

• The transactions could have a minor impact on shareholders' perception of the company, depending on how they interpret the executive's stock sale.

Key Dates